These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22760866)

  • 1. Elevated ApoB serum levels strongly predict early cardiovascular events.
    Gigante B; Leander K; Vikstrom M; Frumento P; Carlsson AC; Bottai M; de Faire U
    Heart; 2012 Aug; 98(16):1242-5. PubMed ID: 22760866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.
    Öhman M; Öhman ML; Wållberg-Jonsson S
    Scand J Rheumatol; 2014; 43(4):259-64. PubMed ID: 24689997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
    Jee SH; Boulware LE; Guallar E; Suh I; Appel LJ; Miller ER
    Arch Intern Med; 2005 Oct; 165(19):2299-304. PubMed ID: 16246998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects.
    Kostapanos MS; Christogiannis LG; Bika E; Bairaktari ET; Goudevenos JA; Elisaf MS; Milionis HJ
    J Stroke Cerebrovasc Dis; 2010; 19(6):497-502. PubMed ID: 20538481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
    Lind L; Vessby B; Sundström J
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men.
    Schmidt C; Fagerberg B; Wikstrand J; Hulthe J
    Atherosclerosis; 2006 Nov; 189(1):178-85. PubMed ID: 16384562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
    Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
    Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
    Meisinger C; Loewel H; Mraz W; Koenig W
    Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels.
    Coss E; Watt KD; Pedersen R; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2011 Jan; 17(1):23-31. PubMed ID: 21254341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events.
    Herder C; Peeters W; Zierer A; de Kleijn DP; Moll FL; Karakas M; Roden M; Meisinger C; Thorand B; Pasterkamp G; Koenig W
    Eur J Clin Invest; 2012 Mar; 42(3):329-37. PubMed ID: 21950567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
    Williams K; Sniderman AD; Sattar N; D'Agostino R; Wagenknecht LE; Haffner SM
    Circulation; 2003 Nov; 108(19):2312-6. PubMed ID: 14581403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.